Recent studies have shown that CXCL10 can enhance the antitumor activity of Th1 cells by inducing the recruitment of CXCR3 and CD8+ T cells to tumor sites and the production of Granzyme‐B induced by these cells.87 This evidence concerns the gene CD8A and neoplasm.